Waters Parkerson & Co’s Sophiris Bio, Inc. SPHS Stock Holding History

Waters Parkerson & Co’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,000	Closed	-$28K	–	172
2018 Q2	$28K	Buy	+10,000	New	+$29.7K	﹤0.01%	164

Other funds holding SPHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ACM

Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return

Waters Parkerson & Co's SPHS Position: Q3 2018 in Review

Waters Parkerson & Co sold out of Sophiris Bio, Inc. (SPHS) in Q3 2018, closing a stake of 10,000 shares — an estimated $28K sold.

Waters Parkerson & Co first reported a position in SPHS in Q2 2018 and held it in 1 quarter. The position peaked at $28K in Q2 2018. 35 funds tracked by Wall St. Rank hold SPHS as of Q3 2018.

Waters Parkerson & Co reported no remaining Sophiris Bio, Inc. position as of Q3 2018 after selling out during the quarter.
Waters Parkerson & Co sold 10,000 Sophiris Bio, Inc. shares in Q3 2018, an estimated $28K.
Waters Parkerson & Co first reported a position in Sophiris Bio, Inc. in Q2 2018 and held it in 1 quarter.
Waters Parkerson & Co's Sophiris Bio, Inc. position peaked at $28K in Q2 2018.
35 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q3 2018.

Based on Waters Parkerson & Co's 13F filing for Q3 2018, filed 13 Nov 2018.